Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Comment by PezDalatoYouon Mar 10, 2017 4:25pm
246 Views
Post# 25966045

RE:The other "Beech Boy" character "longsmallcrapphrma"

RE:The other "Beech Boy" character "longsmallcrapphrma"
A lot of speculation going on here regarding post-approval, etc, etc. I have been a Spectral shareholder since the Bioms dirucitide aftermath. I attended two Bioms AGM in Edmonton (the muffins were delicious) and heard research MDs speak and a coworker's relative worked there and our collective group owned almost 1MM shares between us. I can assure you that no one there knew the outcome of the dirucitide phase 3 trial ahead of the NR. Likewise I don't believe anything nefarious going on with Spectral and I continue to be long. This board is a hoot to follow and read but the speculation BS is getting really thick and it's time to get back to reality. What we know for sure: 1. First quarter results coming soon 2. PMX PMA Module 4 submission news coming soon. 3. Stand alone pump news coming soon. 4. Assuming successful PMX PMA Module 4 submission, in 6 months or so we should have PMX PMA Module 4 FDA decision. I'm hoping it will be an exciting year. It's been a long wait for me. GLTA. Remember it's PezDalatoYou
Bullboard Posts